IRVINE, Calif., Feb. 10, 2012 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today details relating to the release of its fourth quarter and full year 2011 financial results, which will take place on Wednesday, February 22, 2012 after the close of the market.
